Tag:
Symbicort
Latest Headlines
Latest Headlines
Prosonix: Scrap excipients for better respiratory delivery
Prosonix says its new platform for multi-API powders could be the way to boost effectiveness for inhaled treatments.
New year brings new delay for SkyePharma's Flutiform asthma inhaler
It's likely that SkyePharma isn't having a "Happy New Year" just yet. That's because the British drug delivery company now stands to face an additional delay of between 6 and 9 months in the approval
FDA orders tougher warnings on LABA asthma drugs
The FDA has finalized new warnings for inhaled asthma drugs known as long-acting beta-agonists, exercising new powers to order the changes on products made by GlaxoSmithKline ( NYSE: GSK ) and
FDA OKs new use for Symbicort
The FDA has approved AstraZeneca's Symbicort for a new use. Symbicort can now be used to treat asthma and chronic bronchitis, making it far more competitive with the blockbuster Advair. Report
FDA panel votes down two asthma meds
When it came to the vote, the FDA's asthma drugs advisory panel wasn't as evenly split as it seemed. The experts voted unanimously to ban GlaxoSmithKline's Serevent and Schering-Plough/Novartis'
Panel to vote on asthma drugs' fate
A sharply divided FDA advisory committee votes today on whether to restrict long-acting asthma meds. At yesterday's meeting, the expert panel split on the safety of the drugs--Advair, Symbicort,
AZ stock falls on Symbicort patent loss
What a difference one patent ruling can make. AstraZeneca lost almost $1.3 billion in market value today after announcing that the European Patent Office yanked a patent covering its blockbuster
